May 14, 2024 News by Steve Bryson, PhD Balance, cardio training project aims to improve walking ability in MS A Marquette University team is leading a new project that will combine balance and cardio training with the goal of improving the walking abilities of people with multiple sclerosis (MS). Led by Marquette biomedical engineering professor Brian Schmit, PhD, the project ā which is supported by a $3.34 million…
February 9, 2024 News by Mary Chapman Helius to showcase PoNS device at physical therapy meeting Feb. 15-17 Helius Medical Technologies will be showcasing its now-accredited PoNS device ā designed to improve walking ability in people with multiple sclerosis (MS) ā at this year’s American Physical Therapy Association (APTA) Combined Sections Meeting (CMS), slated for Feb. 15-17. The annual meeting, which will feature educational sessions, exhibits,…
January 8, 2024 News by Steve Bryson, PhD Ocrevus in real world may also help severely disabled MS patients Treatment with Ocrevus (ocrelizumab) may stabilize disability progression in people with multiple sclerosis (MS) who have severe walking impairments ā a patient group excluded from clinical trials supporting the therapy’s 2017 approval ā a real-world analysis suggests. However, about half of those receiving Ocrevus in this study discontinued…
October 5, 2023 News by Patricia Inacio, PhD Google Maps Timeline may help in monitoring walking ability in MS Assessing a person’s daily walking patterns using the Google Maps Timeline tool may help doctors remotely monitor fatigue, walking ability, and disease severity in people with multiple sclerosis (MS), a study suggests. The digital tool is built in the smartphone application Google Maps and records daily walking distance and…
September 19, 2022 News by Lindsey Shapiro, PhD Wearable Sensors May Identify MS Patients at Greater Risk of Falls Using wearable sensors to monitor gait during daily life may be a promising way to identify people with multiple sclerosis (MS) who have a greater risk of falling, a study found. The study identified a number of gait differences between those who fell in the year and those who…
November 23, 2020 News by Marisa Wexler, MS ChariotMS to Test Mavenclad in SPMS, PPMS Patients With Little Ability to Walk An upcoming Phase 2 clinical trial, called ChariotMS, will test whether Mavenclad (cladribine) can slow a worsening of hand and arm function in people with progressive multiple sclerosis (MS) and very limited walking abilities. Patients reliant on wheelchairs or aids to walk even short distances generally have…
May 2, 2017 Columns by Ed Tobias My Lemtrada Journey: Do You Think You’re Walking Better? “Do you think you’re walking better?” The question came from my wife, Laura. It’s now about 4 1/2 months since my first round of Lemtrada infusions and I’ve had ups and downs physically. The day she asked, I was feeling pretty good. I also think I’ve been…